MedTrace Logo

ALS Research Collaborative

NCT06885918 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-03-20

No results posted yet for this study

Summary

The goal of this natural history study is to learn more about the biological and clinical aspects of amyotrophic lateral sclerosis (ALS). This study's findings will help with drug discovery, biomarker discovery, and outcome measure validation. Adults living with ALS, other motor neuron diseases (MND), a known mutation related to ALS and healthy volunteers contribute prospective and retrospective data to this study remotely. The study is sponsored and conducted by the ALS Therapy Development Institute.

Conditions

  • Amyotrophic Lateral Sclerosis
  • ALS (Amyotrophic Lateral Sclerosis)
  • ALS With Frontotemporal Dementia (ALS/FTD)
  • Motor Neuron Disease
  • Motor Neuron Disease, Amyotrophic Lateral Sclerosis

Sponsors & Collaborators

  • ALS Therapy Development Institute

    lead OTHER

Principal Investigators

  • Fernando G Vieira, M.D. · ALS Therapy Development Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-12
Primary Completion
2035-01-31
Completion
2035-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06885918 on ClinicalTrials.gov